Skip to content

The effect of a high-fat meal on the immune system

High-fat challenge induced trained innate immunity

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON24430
Enrollment
15
Registered
2018-11-08
Start date
2019-03-04
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atherosclerosis innate immune memory high-fat challenge slagaderverkalking geheugen van het aangeboren afweersysteem vetrijke maaltijd

Interventions

A single high-fat challenge (milkshake containing 95g of fat) and ‘control’ shake (comparable to an average breakfast).

Sponsors

Radboud University Medical Center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Age between 18 and 40 years - LDL cholesterol < 3.5 mmol/l, fasting triglycerides < 2 mmol/l - No previous cardiovascular events

Exclusion criteria

Exclusion criteria: - Smoking within the year before study entry - Diagnosed with any long-term medical condition that can interfere with the study (i.e. renal failure, cardiovascular disease, diabetes, rheumatoid arthritis etc.) - Medication (with the exception of oral contraceptives) or supplement use (i.e. omega3) - BMI 27 kg/m2 - Previous vaccination within 3 months prior to study entry - Current infection or clinically significant infections within 1 month before study entry (defined as fever > 38.5°C) - Allergic to cow milk/dairy products - Pregnancy/lactation

Design outcomes

Primary

MeasureTime frame
The primary endpoint is the TNFa production upon ex vivo stimulation with LPS of monocytes isolated 72h after the consumption of high-fat shake.

Secondary

MeasureTime frame
Additional secondary endpoints are the production of other cytokines and chemokines upon ex vivo stimulation, the monocytes’ inflammatory phenotype as assessed by flowcytometry analysis , epigenetic and metabolic reprogramming and serum induced inflammation.

Contacts

Public ContactJulia van Tuijl

Radboudumc

Julia.vanTuijl@radboudumc.nl024-3667209

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)